themselves . We therefore evaluated these genes for a unique sequence that might contribute to autoimmunity. Because the majority of the polymorphism of class II genes lies in the second exons encoding the first domains, we sequenced the second exons of I-Act, I-A#, I-Ea, and I-Eg of NZW using the technique of the polymerase chain reaction (11) . We report here that the second exons of NZW I-A a and 0 and I-Ea are identical to their counterparts of the previously sequenced u haplotype, and that the second exon of NZW I-Ef3 is identical to the second exon of I-E°O except for single C-G base change at nucleotide position 215 resulting in an arginine for threonine substitution at amino acid position 72. The substituted G and arginine are identical to those found at these positions in the s haplotype .
Materials and Methods
Oligonucleotides . Oligonucleotides corresponding to previously sequenced mouse class II I-Aa, I-AFB, I-Ea, and I-Ef3 genes were constructed using the ABI DNA synthesizer (Applied Biosystems, Inc., Foster City, CA) ( Table I ). The primer oligonucleotides corresponded to the first 18-24 and the last 21-24 bases of the second exon of the I-A genes, the first 19 and the last 21 bases of the second exon of I-Ea, the first 17 and the last 21 bases of the second exon of the I-E0 gene, and the most 3' 21 bases of the first intron and the most 5' 21 bases of the second intron of the I-E0 gene. The screening oligonucleotides for I-Aa and R and I-Ea corresponded to an 18-24 base nonpolymorphic region found in the second exon of these genes.
Polymerase Chain Reaction (PCR). For I-Ace and 0, and for I-E0 and PCR was performed essentially as described in the procedure from the Perkin Elmer Cetus Gene Amp DNA Amplification Reagent kit (see also reference 12) (Perkin Elmer Cetus, Norwalk, CT) . Briefly, 1 p,g of NZW genomic DNA was amplified in a solution of reaction buffer (50 mM KCI, 10 mM Tris-Cl, pH 8.3, 1.5 MM MgC12, 0.01% gelatin), 0.20 mM of each dNTP, 1.0 J,M each of 5' primer and 3' primer, and Taq polymerase (2.5 U) in a total volume of 100 pl. The mixture was overlaid with mineral oil and taken through 30 cycles of amplification (1.5 min at 94°C, 2 min at 50-55°C [42°C for intronic primers], 3 min at 72°C) . The entire reaction was ligated into Sma I-digested M13mpI8, and Escherichia coli strain JM109 was transformed (13) with the ligation mixture . After transformation, plaques were transferred to Nitroplus 2000 (Micron Separations Inc., Westboro, MA) and screened using a third oligonucleotide made to a nonpolymorphic portion ofthe second exon of the class II gene (Table  I) . The probe was end-labeled with 1'-[ 32P]dATP (14) . Filters were prehybridized in 6 x SSC (1 x SSC : 0.15 M NaCl, 0.015 M sodium citrate, pH 7 .0) (15) , 5 x Denhardt's solution (1 x Denhardt's : 0.02% Ficoll, 0.02% polyvinylpyrrolidone, 0.02% BSA), 0.05% sodium pyrophosphate, 100 pg/ml salmon sperm DNA, 0.5 % SDS, and hybridized in 6 x SSC, 1 x Denhardt's, 100 pg/ml yeast tRNA, 0.05% sodium pyrophosphate, and 5 x 106 cpm of each probe per filter at 37°C overnight (16) . The filters were washed at 37°C in 6x SSC, 0.05% sodium pyrophosphate and subjected to autoradiography. Positive plaques were picked and sequenced .
For I-Ea, single-stranded template for sequencing was prepared directly from PCR using a modification of the limiting primer technique (12, 14) . Molar primer ratios of 1 :15 or 1 :20 were used in a PCR reaction solution of 200 or 400 11, using the same constituent concentrations as with the I-Aa and 0, and I-E0 PCRs. The limiting primer was set at a concentration of 10 ng/0.1 ml reaction mixture, and the PCR was run for 40 cycles, with denaturation at 94°C for 2 min, annealing at 55°C for 3 min, and extenstion at 72°C for 2 min. Reaction mixtures that showed the major product band to be the expected size on a 3% agarose gel were selected for sequencing.
DNA Sequencing. Positive plaques were sequenced by the Sanger dideoxy chain termination method (17) using [35S]dATP and the Sequenase DNA Sequencing Kit (U.S. Biochemical Corp., Cleveland, OH). The sequencing reactions were run on 6% denaturing polyacrylamide gels, dried, and subjected to autoradiography Sequence was performed on DNA iso-lated from at least three independent PCRs for each gene to preclude any sequence errors introduced during the PCR .
Southern Analysis. An aliquot of the PCR was electrophoresed on a 3 % Nusieve agarose gel (FMC Bio Products, Rockland, ME) and transferred by the method of Southern (18) to Genescreen plus (New England Nuclear, Boston, MA) . Preparation of the probe and hybridization of the membrane were as described for screening plaques .
Results
NZWIAa. The PCR was performed on NZW genomic DNA using oligonucleotides corresponding to I-A°a and a chain genes ( Table I ). The amplified DNA from each PCR was ligated into M13. Plaques were screened with a third oligonucleotide corresponding to a nonpolymorphic portion ofthe class II gene located within the amplified DNA (Table 1) . Positive plaques were picked and the PCR insert was sequenced. The sequences obtained for the second exons of both NZW I-Act and I-A/3 were identical to those ofthe previously sequenced u haplotype with no nucleotide or amino acid changes. Comparisons between NZW and previously sequenced I-Act genes and polypeptides are shown in Fig. 1 . The isoleucine at position 46 appears to be unique to the I-A°a protein ( Fig. 1 B) , and represents a conservative substitution for the valine found in most haplotypes.
NZW I-A,8. The DNA and protein sequence for the first domain of I-A13 are shown in Fig. 2 . The leucine at position 8 and the tyrosine at position 81 are unique to the I-A°/3 protein and are not found in any other known sequences. The leucine at position 8 represents a conservative change from valine present in most other haplotypes. The tyrosine at 81 is a nonconservative change from the histidine found in most other haplotypes . Of interest, the glutamine at position 85 and valine at position 88 seen in I-A°o and NZW I-A0 are also both found in the NOD I-A(3 molecule (6) and are therefore unique to the u and NOD haplotypes .
NZWI-Ea . The DNA and protein sequences of I-Ea second exons ofNZW and haplotypes u,k, and d are shown in Fig. 3 . The I-Ea second exons of NZW and u are identical, but differ from the other known haplotypes by two changes, as previously reported (19) . The tyrosine for phenylalanine substitution at position 22 is a conservative one, while the lysine for glutamic acid substitution at position 75 is nonconservative. NZW 1-E, 8 . PCR was performed on NZW genomic DNA using oligonucleotides corresponding to known I-E/3 sequences of several haplotypes (Table I) . Because of initial difficulties in isolating amplified DNA corresponding to the NZW I-E(3 second exon, an additional methodological step was introduced to ensure that the NZW I-E/3 second exon was actually being amplified. A portion of each PCR was electrophoresed through an agarose gel and blotted onto nitrocellulose; the filter was hybridized with a third oligonucleotide corresponding to the nonpolymorphic nucleotides 40-60 of I-ES (Table I ). B10.BR genomic DNA (k haplotype) and oligonucleotides to the k haplotype were used as a positive control. A band at -270 by corresponding to amplfied I-E(3 from the k haplotype was seen . Also present, but to a lesser extent, was amplified DNA corresponding to NZW I-E(3 (data not shown) . With this assurance, the amplified DNA from the latter PCR was ligated into M13. Plaques were again screened with the nonpolymorphic I-EBB oligonucleotide 40-60, positive plaques were picked, and the PCR insert was sequenced with the nonpoly- morphic I-EO oligonucleotide 40-60, positive plaques were picked, and the PCR insert was sequenced. Fig. 4 shows a comparison between I-E)3 nucleotide and amino acid sequences, respectively, from various haplotypes . The sequence of the second exon of the NZW I-EO gene corresponds to the previously sequenced u haplotype except for a single nucleotide change (C-G) at base 215. This change was confirmed by sequencing 12 independent clones isolated from five independent PCRs representing both orientations . Two of these clones were isolated from PCRs in which only intronic oligonucleotides flanking the second exon were used as primers. This change results in a nonconservative amino acid substitution at position 72 where a threonine is replaced by an arginine. Of note, both the substituted G and arginine are also present in the I-E$/3 gene and polypeptide, respectively, at the corresponding positions.
Discussion
In this study we demonstrate that within the limits of the PCR and choice of primers, the sequences of the second exons of NZW I-Act, I-A(3, and I-Ece are all identical to those of the previously sequenced u haplotype, while the second exon of NZW I-Ea is identical to that of the u haplotype except for a change at amino acid 72 . Because the PCR amplifies the oligonucleotides used as primers for the amplification of the second exon, it is possible that a single base change present in the region of the second exon annealing to the primer could be missed . For this reason we cannot exclude a single base difference (potentially resulting in an amino acid difference) between u and NZW in these regions of I-Atx, I-Ag, and I-Em However, the use of oligonucleotides corresponding to the intronic sequences flanking the second exon of NZW I-Efl confirm that the sequences of I-E°o and NZW I-EBB second exons are identical except for the single base change . Previous work has demonstrated that the contribution of NZW to accelerated autoimmunity in the (NZB x NZW)FL mouse is linked to the H-2 complex (7). Our finding of a unique sequence in the NZW class II I-Ef3 chain may offer a possible explanation for this finding. In a related model, the (NZB x SWR)Fj mouse, it has been shown that the contribution of the SWR strain (q haplotype) to the development of nephritis is linked to the I-Ag locus (as well as the TCR (3 chain gene) (9) . Furthermore, results demonstrating an amino acid unique to the I-A/3 chain in the NOD (6) mouse and the importance of amino acid 57 in the human DW chain contribution to diabetes (1, 2) suggest that single amino acid changes in class II molecules may contribute to the development of autoimmunity. In this context, it is possible that the arginine at position 72 that differentiates the NZW I-ES sequence from the I-E°(3 sequence from the I-Eua sequence may contribute to the accelerated autoimmunity seen in the (NZB x NZW)F1 . This hypothesis is supported by the postulated class II three-dimensional structure (20) that places this arginine on the a-helix, where is may influence .interaction with antigen or TCR. In addition, five amino acids encoded by the second exon are unique to the NZW (u) I-E0 chain (i.e., not present in any other known haplotypes). Many ofthe amino acids unique to the NZW I-E0 chain are located at positions, which based on the hypothetical model of the three-dimensional structure of a class II molecule (20) , have the potential to interact with antigen and/or TCR. A comparison ofthe known class II sequences from the "autoimmune" haplotypes (q, NOD, and NZW) suggests that other NZW class II molecules may also be important in contributing to autoimmunity. As mentioned in Results, the isoleucine at position 46 in I-Act and the leucine at position 8 and tyrosine at position 81 in I-A# are unique to the NZW (u) haplotype. According to the three-dimensional (Fig . 2) , suggesting that a gene conversion event involving these two haplotypes may be one explanation for this region of shared sequence. Based on the hypothetical structure of a class II molecule (20) , it is unclear what role valine at position 15 in the a chain, or glutamine 85 or valine 88 in the R chain may play in antigen presentation, as they do not appear likely to interact with antigen. However, tertiary structural changes induced by these amino acids may be responsible for the contribution of these sequences to autoimmunity.
Although the sequence of NZW I-Ea is identical at the second exon to that of the u haplotype, this sequence still codes two unique amino acid residues relative to other known Ea haplotypes, and may play a role in (NZB x NZW)Fi autoimmunity. The lysine at position 75 is unique to the NZW and the u haplotypes relative to k and d, but the site lies outside the antigen binding groove of the constructed computer model for the class II molecule . The unique tyrosine residue at position 22, however, is near the floor of the groove to one side where one a-helix of ESjuxtaposes against the Ea molecule, and could interact with bound antigen. Furthermore, H-2°haplotype mice have been shown to have an Ea molecule that does not consistently associate well with non-u E/3 molecules in heterozygote Fi hybrid crosses, interfering with certain E-restricted immune responses (19) . This finding could be significant in the (NZB x NZW)F, model also, in light of the NZW identity with the second exon of I-Eau.
While the unique sequence of the NZW I-Eg chain provides one explanation for the contribution of NZW to accelerated autoimmunity, several other explanations exist. It is possible that there may be trans-association between individual class II chains determined by NZB (H-2d) and NZW to form "hybrid" molecules. This hypothesis is supported by results suggesting that administration of anti-I-A d antibodies to (NZB x NZW)F, mice improved their survival (10) .
An additional possibility is that the NZW and H-2u class II molecules may be immunodominant, and in this way contribute to accelerated autoimmunity. Several observations support this hypothesis . PL/J is u haplotype (21, 22) , and is involved in experimental allergic encephalomyelitis (EAE), the animal model of human multiple sclerosis (23, 24) . The NH2-terminal 37 amino acids of rat myelin basic protein (MBP) can induce EAE in PL/J mice, while the COON-terminal 89-169 amino acid peptide is encephalitogenic in SJL/J mice (s haplotype) . However, the (PLJ x SJL)Fj mouse develops EAE only in response to the NH2-terminal peptide of MBP (23, 24) , suggesting that the u haplotype is immunodominant in this autoimmune response . This hypothesis is supported by the observation that of 16 I-A-restricted T cell clones recognizing MBP, only one is I-A$ restricted (23, 24 ). An analogous situation may exist in (NZB x NZW)Fi lupus mice. It is possible that the I-A°mol-ecule contributed by the NZW mouse is immunodominant and may thereby predispose to self recognition.
One possible mechanism for such immunodominance derives from the concept of preferential expression ofone haplotype over another. In support of this concept, it has been demonstrated that in (d x u)Fj mice there is a poor expression of I-Ed molecules. This poor expression is apparently due to a preferential association of E°(3 chains with the Ect chains present (25) . It is possible that a similar phenomenon is occurring in (NZB x NZW)Fj mice .
Because both NZW and PL/J (H-2°) mice have been associated with autoimmunity, it would be of interest to evaluate (NZB x PL/J)Fi mice for the presence of a lupus-like disease, and if it is present, to compare disease severity between (NZB x NZW)F, and (NZB x PL/J)Fl mice. To our knowledge, the (NZB x PL/J)Fl mice have not yet been produced. A similar degree of disease severity might suggest the u haplotype per se was contributing to autoimmunity. Absence ofdisease or minimally severe disease in the (NZB x PL/J)F, compared with the (NZB x NZW)Fi would suggest that the substitution at position 72 in the I-E0 chain and/or NZW background genes are critical for the developmental of accelerated autoimmunity. However, differences in background genes between PL/J and NZW would preclude any definitive conclusions.
It is clear that the NZW mouse is not the only strain that contributes to accelerated autoimmunity, as the SWR (q) mouse when crossed to NZB produces a similar picture. It is therefore likely that no one class II haplotype is uniquely involved in the development of autoimmunity, and that several, if not all, haplotypes may encode class II molecules permissive for the development of disease. Study of additional class II sequences should further elucidate the mechanisms by which specific changes in sequence may predispose to disease and autoimmunity. Summary The (NZB x NZW)F, mouse strain develops a syndrome of accelerated autoimmunity including severe renal disease and early death. Evidence suggests that class II molecules play a central role in this process. Previous studies have suggested that the NZW strain contributes at least one gene to the development of accelerated autoimmunity that is linked to the H-2 complex, and antibodies to murine class II molecules have been used to ameliorate disease in (NZB x NZW)Fi mice . We therefore wished to sequence the class II molecules from NZW mice to identify any unique sequences that may contribute to disease development. We constructed oligonucleotide primers corresponding to the 5' and 3' regions of the second exon of class II genes from a variety of haplotypes, and used these primers in a polymerase chain reaction to sequence the second exon ofthe NZW I-Act, I-Ag, and I-E/3 genes. We report that the second exons of NZW I-Aci, I-A(3, and I-Ea are identical to their counterparts of the previously sequenced u haplotype, and that the second exon of NZW I-E/3 is identical to its counterpart from u except for a single base change that results in a substitution of arginine for threonine at amino acid 72. This base and amino acid are identical to those found at the same positions in the s haplotype.
